Jacobio Pharmaceuticals Group (HKG:1167) said a group of shareholders increased their shareholdings in the company, according to a Hong Kong bourse filing Monday.

The said group purchased 854,400 shares of the company at HK$5.88 apiece from the open market between July 16 and July 18, and did not rule out the possibility of further entrenching their shareholding in the business, Jacobio said.

The group now owns nearly 200.5 million shares of the company representing 25.32% of its issued share capital, according to Jacobio.